These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 34204026)
1. Docking-Based 3D-QSAR Studies for 1,3,4-oxadiazol-2-one Derivatives as FAAH Inhibitors. Zięba A; Laitinen T; Patel JZ; Poso A; Kaczor AA Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204026 [TBL] [Abstract][Full Text] [Related]
2. 3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors. Patel PD; Patel MR; Kaushik-Basu N; Talele TT J Chem Inf Model; 2008 Jan; 48(1):42-55. PubMed ID: 18076152 [TBL] [Abstract][Full Text] [Related]
3. CoMFA and CoMSIA 3D-QSAR analysis of DMDP derivatives as anti-cancer agents. Srivastava V; Kumar A; Mishra BN; Siddiqi MI Bioinformation; 2008 Jun; 2(9):384-91. PubMed ID: 18795111 [TBL] [Abstract][Full Text] [Related]
4. Improved 3D-QSAR Prediction by Multiple Conformational Alignments and Molecular Docking Studies to Design and Discover HIV-I Protease Inhibitors. Patel PK; Bhatt HG Curr HIV Res; 2021; 19(2):154-171. PubMed ID: 33213349 [TBL] [Abstract][Full Text] [Related]
5. Docking-based 3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) study on hydroquinoline and thiazinan-4-one derivatives as selective COX-2 inhibitors. Dowlati Beirami A; Hajimahdi Z; Zarghi A J Biomol Struct Dyn; 2019 Jul; 37(11):2999-3006. PubMed ID: 30035675 [TBL] [Abstract][Full Text] [Related]
6. CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site. Buolamwini JK; Assefa H J Med Chem; 2002 Feb; 45(4):841-52. PubMed ID: 11831895 [TBL] [Abstract][Full Text] [Related]
7. 3D QSAR pharmacophore, CoMFA and CoMSIA based design and docking studies on phenyl alkyl ketones as inhibitors of phosphodiesterase 4. Gaurav A; Singh R Med Chem; 2012 Sep; 8(5):894-912. PubMed ID: 22741782 [TBL] [Abstract][Full Text] [Related]
8. 3D-QSAR Studies on Barbituric Acid Derivatives as Urease Inhibitors and the Effect of Charges on the Quality of a Model. Ul-Haq Z; Ashraf S; Al-Majid AM; Barakat A Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27144563 [TBL] [Abstract][Full Text] [Related]
9. Docking-based CoMFA and CoMSIA studies on naphthyl-substituted diarylpyrimidines as NNRTIs. Wu HQ; Yao J; He QQ; Chen FE SAR QSAR Environ Res; 2014; 25(10):761-75. PubMed ID: 25242254 [TBL] [Abstract][Full Text] [Related]
10. CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators. Gajjar KA; Gajjar AK Curr Drug Discov Technol; 2020; 17(1):100-118. PubMed ID: 30160214 [TBL] [Abstract][Full Text] [Related]
11. Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking. Sun G; Fan T; Zhang N; Ren T; Zhao L; Zhong R Molecules; 2016 Jun; 21(7):. PubMed ID: 27347909 [TBL] [Abstract][Full Text] [Related]
12. 3D-QSAR studies on CCR2B receptor antagonists: Insight into the structural requirements of (R)-3-aminopyrrolidine series of molecules based on CoMFA/CoMSIA models. Gade S; Mahmood S J Pharm Bioallied Sci; 2012 Apr; 4(2):123-33. PubMed ID: 22557923 [TBL] [Abstract][Full Text] [Related]
13. 3D-QSAR studies on thiazolidin-4-one S1P₁receptor agonists by CoMFA and CoMSIA. Qian C; Zheng J; Xiao G; Guo J; Yang Z; Huang L; Chao W; Rao L; Sun P Int J Mol Sci; 2011; 12(10):6502-16. PubMed ID: 22072901 [TBL] [Abstract][Full Text] [Related]
14. Computational Analysis of CRTh2 receptor antagonist: A Ligand-based CoMFA and CoMSIA approach. Babu S; Sohn H; Madhavan T Comput Biol Chem; 2015 Jun; 56():109-21. PubMed ID: 25935115 [TBL] [Abstract][Full Text] [Related]
15. Docking-based 3D-QSAR study of pyridyl aminothiazole derivatives as checkpoint kinase 1 inhibitors. Balupuri A; Balasubramanian PK; Gadhe CG; Cho SJ SAR QSAR Environ Res; 2014; 25(8):651-71. PubMed ID: 24911214 [TBL] [Abstract][Full Text] [Related]
16. CoMFA and CoMSIA 3D-QSAR analysis of diaryloxy-methano-phenanthrene derivatives as anti-tubercular agents. Shagufta ; Kumar A; Panda G; Siddiqi MI J Mol Model; 2007 Jan; 13(1):99-109. PubMed ID: 16858589 [TBL] [Abstract][Full Text] [Related]
17. 3D-QSAR and molecular docking study of LRRK2 kinase inhibitors by CoMFA and CoMSIA methods. Pourbasheer E; Aalizadeh R SAR QSAR Environ Res; 2016 May; 27(5):385-407. PubMed ID: 27228480 [TBL] [Abstract][Full Text] [Related]
18. Insight into the structural requirements of proton pump inhibitors based on CoMFA and CoMSIA studies. Nayana MR; Sekhar YN; Nandyala H; Muttineni R; Bairy SK; Singh K; Mahmood SK J Mol Graph Model; 2008 Oct; 27(3):233-43. PubMed ID: 18676164 [TBL] [Abstract][Full Text] [Related]
19. CoMFA and CoMSIA 3D-QSAR analysis on hydroxamic acid derivatives as urease inhibitors. Ul-Haq Z; Wadood A; Uddin R J Enzyme Inhib Med Chem; 2009 Feb; 24(1):272-8. PubMed ID: 18608766 [TBL] [Abstract][Full Text] [Related]
20. QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA. Sainy J; Sharma R SAR QSAR Environ Res; 2015; 26(10):873-92. PubMed ID: 26524489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]